-
Dual Devices By Pitt Researchers Harness Carbon Nanomaterials For Enhanced Drug Delivery Systems, Oxygen Sensors
8/18/2009
Two nanoscale devices recently reported by University of Pittsburgh researchers in two separate journals harness the potential of carbon nanomaterials to enhance technologies for drug or imaging agent delivery and energy storage systems, in one case, and, in the other, bolster the sensitivity of oxygen sensors essential in confined settings, from mines to spacecrafts.
-
CryoStim™ Cancer Treatment To Begin FDA Clinical Trials September 1, 2009
8/16/2009
Immunovative Therapies Ltd. has announced that its CryoStim™ experimental product has been cleared by the FDA to begin human clinical trials. Immunovative Therapies, Ltd. experimental products are based upon “Mirror Effect™” technology (patents issued and pending) which is designed to provide the same anti-tumor effect that has been proven to be curative in allogeneic bone marrow transplant (BMT) procedures without the lethal toxicity or need for a matched donor.
-
Pharmaceutical Tablets: To Image Or Not To Image?
8/13/2009
Spectroscopy specialists at Malvern Instruments have published a guidance document that sets out the most important points to consider when purchasing a laboratory-based spectroscopic tablet analysis system.
-
Grant Instruments Expands Data Logging Range With Acquisition Of Assets And IP Of California-Based Company Accsense
8/11/2009
Grant Instruments, a world-renowned supplier and manufacturer of own-brand scientific, life sciences and data acquisition products, has acquired the assets and intellectual property of California-based Accsense, Inc., a company that designs remote monitoring systems using self healing wireless mesh network technology.
-
Biota Holdings Announces Successful Phase III Asian Clinical Trials Of Its Second Generation Flu Treatment
8/11/2009
Biota Holdings Limited (ASX: BTA) today announced successful results from the Asian Phase III clinical trials of CS-8958, its second generation influenza treatment.
-
Smart Characterization For Smart Polymer Science - Malvern’s Zetasizer Nano Emerges As The System Of Choice
8/10/2009
As researchers discover new and widespread applications for stimulus-responsive microgels, known as ‘smart polymers’, the Zetasizer Nano system from Malvern Instruments is fast emerging as their system of choice for particle characterization.
-
Position Paper Highlights Advancements In Balance Enclosure Technology
8/3/2009
Labconco Corporation offers an 8-page white paper titled, “Advances in Balance Enclosure Technology Bring Safety Enhancements to the Pharmaceutical Industry.”
-
Emerson Introduces Multiparameter Intelligent Analyzer With Three Measurement Inputs
8/1/2009
To meet the need for multiple liquid measurements and lower costs per measurement loop required by industrial OEMs and other analytical customers, Emerson Process Management has announced the Rosemount Analytical Model 1057 three-input intelligent analyzer.
-
M2S Announces New Clinical Trial Product, iMAS, A Medical Image Collect And Hold Solution
7/30/2009
M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, today announced that it has launched a new product to collect and hold medical images in clinical trials, called iMAS (Image Management Archive System).
-
ICON Selected To Manage Lilly Clinical Trial Site Set Up And Monitoring In Europe
7/30/2009
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, recently announced that it has signed a strategic partnership with Eli Lilly and Company to manage the company’s clinical trial site set up and monitoring in Europe for Lilly managed studies.
